CPHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
China Pharma Holdings Inc (CPHI) is not a good buy for a beginner investor with a long-term strategy at this time. The company shows weak financial performance, no positive trading signals, and lacks significant positive catalysts. Additionally, technical indicators do not suggest a strong entry point, and there is no recent news or influential trading activity to support a bullish case.
The MACD is slightly positive but contracting, RSI is neutral at 27.039, and moving averages are converging, indicating no clear trend. The stock is trading below its pivot level (0.65), with key support at 0.572 and resistance at 0.698. Overall, technical indicators suggest a lack of momentum.
NULL identified. No recent news, no significant hedge fund or insider activity, and no influential trading data.
The stock dropped 8.96% in regular market trading. Financial performance is weak, with declining EPS (-66.04% YoY) and gross margin (-186.86% YoY). The stock has a 60% chance of declining further in the next week and month.
In Q4 2025, revenue increased by 8.11% YoY to $1,225,997, but net income dropped to -$1,222,135 (-0.19% YoY). EPS fell significantly by 66.04% YoY to -0.18, and gross margin dropped sharply to 12.3%, down -186.86% YoY.
No analyst ratings or price target changes available.
